Most pharmacies start with a single supplier relationship, and for a new account that is often the right way to begin. As order volume grows, though, relying on one source for every product creates a single point of failure. A shortage, an allocation limit, or a delivery delay from one supplier can leave you scrambling, even when your relationship with wholesale pharmaceutical distributors has otherwise been reliable. A deliberate multi-wholesaler strategy addresses that risk without turning your ordering process into a full-time job.
Why Pharmacies Build a Multi-Wholesaler Strategy With Wholesale Pharmaceutical Distributors
Drug shortages are not a rare event in U.S. pharmacy operations. The American Society of Health-System Pharmacists' most recent national tracking found 216 active drug shortages, even as new shortages in 2025 fell to their lowest annual total since 2006. Shortages concentrated in categories like CNS medications, antimicrobials, and injectables can affect any pharmacy's ability to fill a prescription through a single source, regardless of how strong that relationship is.
New drug shortages fell to 89 in 2025, the lowest annual total in nearly two decades, while 216 shortages remained active nationally as many longstanding supply gaps persisted. (Source: American Society of Health-System Pharmacists, 2025 year-end report)
A second, well-vetted supplier relationship gives a pharmacy somewhere to turn when a primary source cannot fill an order, without the operational overhead of managing five or six accounts at once.
How Many Wholesalers Is Enough?
Most independent pharmacies that adopt a multi-source strategy settle on two to three relationships, structured around a clear role for each:
- Primary supplier — carries the largest share of routine ordering and generic volume, chosen for catalog depth and account support
- Secondary supplier — used for backorder coverage, shortage substitution, and occasional price comparison
- Specialty or niche supplier — added only if a specific therapeutic category, such as compounding ingredients or specialty biologics, is not well covered by the primary and secondary accounts
Adding suppliers beyond this structure tends to increase administrative burden, invoice reconciliation, and compliance recordkeeping faster than it improves fill rates.
A Practical Scenario
Consider a pharmacy that sources 100 percent of its generic inventory from one supplier and is notified mid-month of an allocation limit on a widely prescribed medication. Without a second relationship in place, the pharmacy has to manually search for an alternate source, verify that source's licensing and compliance documentation under time pressure, and absorb a higher price for a one-off purchase. A pharmacy with an established secondary account can typically place a substitute order the same day, using a relationship whose credentials were already verified long before the shortage hit. The difference is not just convenience. It is the gap between a routine substitution and a documented patient-care disruption.
Structuring the Split Without Losing Leverage
One common mistake is splitting volume too evenly between suppliers early on. Order volume is one of the main factors that determines credit terms and pricing tiers, so spreading purchases thin across three or four accounts can leave a pharmacy without enough volume anywhere to negotiate meaningfully. A more effective approach keeps 70 to 80 percent of routine volume with a primary supplier and reserves the remainder for backup coverage, revisiting that split periodically as order history builds.
Compliance Considerations When Sourcing From Multiple Wholesalers
Working with more than one distributor does not reduce your DSCSA obligations; it multiplies the number of trading partners whose documentation you need to track. Each supplier should be able to provide current state licensing, verify product identifiers at the package level, and exchange electronic transaction data consistently. A pharmacy adding a secondary or specialty supplier should apply the same verification standard used for its primary relationship, rather than treating a backup account as lower priority for compliance review.
Evaluating medical supply wholesale distributors as a secondary source
- Are they licensed in your state, with current NABP accreditation and FDA-registered facilities?
- Can they document DSCSA traceability and product verification the same way your primary supplier does?
- What is their typical turnaround time for a backorder or substitution request?
- Do their order minimums and payment terms fit a backup role rather than primary volume?
- Is their generic catalog broad enough to cover meaningful gaps from your primary supplier?
Where Drugzone Fits Into This Picture
Drugzone Pharmaceuticals Inc. is a nationally licensed pharmaceutical distributor that pharmacies use in both primary and secondary sourcing roles, and it is one of the wholesale pharmaceutical distributors pharmacies most often add specifically for backup coverage during shortage events. Drugzone is licensed to distribute across all 50 U.S. states, is NABP-accredited and FDA-registered, and sources from a network of more than 75 manufacturers to support a catalog of more than 2,000 generic pharmaceutical SKUs. Product movement is tracked through a 20,000-square-foot temperature-controlled distribution facility, and a dedicated team of more than 40 sales and account professionals supports pharmacies whether Drugzone is their main supplier or a backup source for shortage coverage.
Pharmacies evaluating where a second or third supplier fits into their sourcing strategy can speak with a distribution specialist to review catalog overlap, account requirements, and compliance documentation.
Frequently Asked Questions
1. Why shouldn't a pharmacy rely on just one supplier?
A single source creates a single point of failure. Shortages, allocation limits, and delivery delays from wholesale pharmaceutical distributors happen regularly enough that a backup relationship protects fill rates and reduces the time staff spend sourcing substitutes.
2. How should I split order volume between a primary and secondary supplier?
Most pharmacies keep 70 to 80 percent of routine volume with a primary supplier to preserve pricing and credit leverage, using the remainder for backup coverage. Splitting volume too evenly across multiple accounts early on can weaken your negotiating position with any single supplier.
3. Does adding a second wholesaler complicate DSCSA compliance?
It increases the number of trading partners you need to verify, but it does not change the underlying requirement. Every supplier, primary or secondary, should be able to document licensing and electronic product tracing to the same standard.
4. When should a pharmacy add a specialty or niche supplier?
Only when a specific therapeutic category, such as compounding ingredients or specialty biologics, is not adequately covered by a primary and secondary supplier. Adding suppliers beyond a clear need usually increases administrative work faster than it improves availability.
5. How often should a multi-wholesaler strategy be reviewed?
Reviewing supplier splits, fill rates, and terms annually, or after any significant shortage event, helps a pharmacy confirm its sourcing structure still matches its order volume and risk tolerance.
Sign in to leave a comment.